Skandinaviska Enskilda Banken (SEB)’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $4.62M | Sell |
|
|||||
|
2024
Q4 | $23.3M | Hold |
|
|||||
|
2024
Q3 | $20.4M | Buy |
|
|||||
|
2024
Q2 | $17.7M | Buy |
|
|||||
|
2024
Q1 | $9M | Sell |
|
|||||
|
2023
Q4 | $20.8M | Sell |
|
|||||
|
2023
Q3 | $21M | Hold |
|
|||||
|
2023
Q2 | $25.6M | Buy |
|
|||||
|
2023
Q1 | $14.5M | Sell |
|
|||||
|
2022
Q4 | $19.8M | Sell |
|
|||||
|
2022
Q3 | $17.8M | Hold |
|
|||||
|
2022
Q2 | $21.9M | Sell |
|
|||||
|
2022
Q1 | $24M | Sell |
|
|||||
|
2021
Q4 | $20.7M | Buy |
|
|||||
|
2021
Q3 | $10.9M | Hold |
|
|||||
|
2021
Q2 | $11.9M | Buy |
|
|||||
|
2021
Q1 | $874K | Buy |
|